Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Robert A. Lasser, MD
JCP
Original Research
Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/ Hyperactivity Disorder Who Report Clinically Significant Impairment in Executive Function: Results From a Randomized, Double-Blind, Placebo-Controlled Study
July 15, 2013
Lenard A. Adler
,
Bryan Dirks
,
Patrick F. Deas
, et al
JCP
Original Research
Lifespan Persistence of ADHD: The Life Transition Model and Its Application
January 10, 2012
Atilla Turgay
,
David W. Goodman
,
Philip Asherson
, et al
JCP
Original Research
A 1-Year Double-Blind Study of 2 Doses of Long-Acting Risperidone in Stable Patients With Schizophrenia or Schizoaffective Disorder.
August 15, 2006
George M. Simpson
,
Ramy A. Mahmoud
,
Robert A. Lasser
, et al
JCP
Letter to the Editor
Methodological Issues in a Comparative Study of Ziprasidone and Risperidone
January 16, 2006
Georges M. Gharabawi
,
Cynthia A. Bossie
,
Ramy Mahmoud
, et al
JCP
Original Research
Combining Serotonin Reuptake Inhibitors and Bupropion in Partial Responders to Antidepressant Monotherapy
April 15, 1997
J. Alexander Bodkin
,
Robert A. Lasser
,
James D. Wines, Jr.
, et al
